Insider Transactions in Q3 2021 at Igm Biosciences, Inc. (IGMS)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2021
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
130
+10.55%
|
-
|
|
Sep 30
2021
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
211
+9.29%
|
-
|
|
Sep 30
2021
|
Michael D Loberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
300
+50.0%
|
-
|
|
Sep 30
2021
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
195
+0.53%
|
-
|
|
Sep 30
2021
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
130
+0.23%
|
-
|
|
Sep 30
2021
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
130
+0.0%
|
-
|
|
Sep 03
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,244
-28.92%
|
$87,080
$70.69 P/Share
|
|
Sep 01
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,256
-22.6%
|
$89,176
$71.79 P/Share
|
|
Sep 01
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+31.03%
|
$0
$0.93 P/Share
|
|
Aug 09
2021
|
Julie Hambleton |
SELL
Open market or private sale
|
Direct |
1,000
-33.33%
|
$80,000
$80.0 P/Share
|
|
Aug 04
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,242
-28.89%
|
$83,214
$67.0 P/Share
|
|
Aug 02
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,258
-22.64%
|
$83,028
$66.96 P/Share
|
|
Aug 02
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+31.03%
|
$0
$0.93 P/Share
|
|
Jul 08
2021
|
Michael D Loberg Director |
BUY
Bona fide gift
|
Indirect |
300
+2.26%
|
-
|
|
Jul 08
2021
|
Michael D Loberg Director |
SELL
Bona fide gift
|
Direct |
300
-100.0%
|
-
|
|
Jul 06
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
943
-0.8%
|
$77,326
$82.75 P/Share
|
|
Jul 06
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
1,247
-28.97%
|
$102,254
$82.5 P/Share
|
|
Jul 01
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
957
-0.81%
|
$85,173
$89.43 P/Share
|
|
Jul 01
2021
|
Daniel Shin Yu Chen Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,900
+1.58%
|
$1,900
$1.39 P/Share
|
|
Jul 01
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,253
-22.55%
|
$111,517
$89.43 P/Share
|
|
Jul 01
2021
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+31.03%
|
$0
$0.93 P/Share
|